Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Roland Foulkes"'
Autor:
Nina Elizabeth Saxton, Barbara T. Janczynski, Karen Zinkewich-Peotti, Heather Margaret Ladyman, Roland Foulkes, Richard S. Smith, Rhona V. Hallaway, Andrew M. Nesbitt
Publikováno v:
Transplantation. 67:1599-1606
Background Several groups have achieved graft acceptance in the concordant hamster to rat model by using a combination of anti-proliferative drugs and conventional immunosuppressive therapy. However, such aggressive treatment often leads to the recip
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 4(11)
Treatment of kidney graft recipients with antibodies that may specifically suppress the anti-donor response would be an ideal situation to prevent graft rejection. MHC class-II-specific antibodies and, in particular, DR specific antibodies have often
Autor:
Andrew Nesbitt, Neil Gozzard, Mark B. Baker, Roger Palframan, Roland Foulkes, Adrian Moore, Alex Vugler
Publikováno v:
American Journal of Gastroenterology. 102:S472
Autor:
A. Nesbitt, M. Liu, Nina Elizabeth Saxton, Richard S. Smith, Roland Foulkes, Michael E. Shapiro
Publikováno v:
Transplantation. 65:S97
Publikováno v:
Journal of Hypertension. 5:637-644
Autor:
Ellen Garber, Christopher Peters, Alison Maloney, Ali Amirkhosravi, David L. Hutto, Linda C. Burkly, Roland Foulkes, Neil Weir, Alastair D. G. Lawson, Frederick R. Taylor, Derek Thomas Brown, Martyn K. Robinson, Todd Meyer, Olivier A. Harari, John L. Francis, Ian Wakefield, Janine Ferrant, Timothy Bourne, Sarah Malcolm, Yen-Ming Hsu, Stevan Shaw, Lihe Su, Anthony Shock
Publikováno v:
Arthritis Research & Therapy
Introduction CD40 ligand (CD40L) blockade has demonstrated efficacy in experimental autoimmune models. However, clinical trials of hu5c8, an anti-human CD40L IgG1 antibody, in systemic lupus erythematosus (SLE) were halted due to an increased inciden